BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26915128)

  • 1. Network-Based Method for Inferring Cancer Progression at the Pathway Level from Cross-Sectional Mutation Data.
    Wu H; Gao L; Kasabov NK
    IEEE/ACM Trans Comput Biol Bioinform; 2016; 13(6):1036-1044. PubMed ID: 26915128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.
    Raphael BJ; Vandin F
    J Comput Biol; 2015 Jun; 22(6):510-27. PubMed ID: 25785493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying overlapping mutated driver pathways by constructing gene networks in cancer.
    Wu H; Gao L; Li F; Song F; Yang X; Kasabov N
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 25859819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUFFINN: cancer gene discovery via network analysis of somatic mutation data.
    Cho A; Shim JE; Kim E; Supek F; Lehner B; Lee I
    Genome Biol; 2016 Jun; 17(1):129. PubMed ID: 27333808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
    Fleck JL; Pavel AB; Cassandras CG
    BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer.
    Ruffalo M; Koyutürk M; Sharan R
    PLoS Comput Biol; 2015 Dec; 11(12):e1004595. PubMed ID: 26683094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiscale mutation clustering algorithm identifies pan-cancer mutational clusters associated with pathway-level changes in gene expression.
    Poole W; Leinonen K; Shmulevich I; Knijnenburg TA; Bernard B
    PLoS Comput Biol; 2017 Feb; 13(2):e1005347. PubMed ID: 28170390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Gene Discovery by Network Analysis of Somatic Mutations Using the MUFFINN Server.
    Han H; Lehner B; Lee I
    Methods Mol Biol; 2019; 1907():37-50. PubMed ID: 30542989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.
    Zhang J; Zhang S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):988-998. PubMed ID: 28113329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Combinatorial Mutational Patterns in Human Cancer Genomes by Exclusivity Analysis.
    Tan H; Zhou X
    Methods Mol Biol; 2018; 1711():3-11. PubMed ID: 29344882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network perturbation by recurrent regulatory variants in cancer.
    Jang K; Kim K; Cho A; Lee I; Choi JK
    PLoS Comput Biol; 2017 Mar; 13(3):e1005449. PubMed ID: 28333928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferring tumor progression in large datasets.
    Mohaghegh Neyshabouri M; Jun SH; Lagergren J
    PLoS Comput Biol; 2020 Oct; 16(10):e1008183. PubMed ID: 33035204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient methods for identifying mutated driver pathways in cancer.
    Zhao J; Zhang S; Wu LY; Zhang XS
    Bioinformatics; 2012 Nov; 28(22):2940-7. PubMed ID: 22982574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrated Framework for Identifying Mutated Driver Pathway and Cancer Progression.
    Zhang W; Wang SL
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(2):455-464. PubMed ID: 29990286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network-based approach reveals Y chromosome influences prostate cancer susceptibility.
    Khosravi P; Gazestani VH; Asgari Y; Law B; Sadeghi M; Goliaei B
    Comput Biol Med; 2014 Nov; 54():24-31. PubMed ID: 25199846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the Sample Complexity of Cancer Pathways Identification.
    Vandin F; Raphael BJ; Upfal E
    J Comput Biol; 2016 Jan; 23(1):30-41. PubMed ID: 26645471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of pathway mutation profiles highlights collaboration between cancer-associated superpathways.
    Gu Y; Zhao W; Xia J; Zhang Y; Wu R; Wang C; Guo Z
    Hum Mutat; 2011 Sep; 32(9):1028-35. PubMed ID: 21618647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering oncogenic drivers: from single genes to integrated pathways.
    Chen J; Sun M; Shen B
    Brief Bioinform; 2015 May; 16(3):413-28. PubMed ID: 25378434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity.
    Tan H; Bao J; Zhou X
    Sci Rep; 2015 Jul; 5():12566. PubMed ID: 26212640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.